Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis
- PMID: 22084232
- PMCID: PMC6942691
- DOI: 10.1001/archophthalmol.2011.331
Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis
Figures


Comment on
-
A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group.Arch Ophthalmol. 1989 Dec;107(12):1759-66. doi: 10.1001/archopht.1989.01070020841024. Arch Ophthalmol. 1989. PMID: 2556989 Clinical Trial.
References
-
- Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ; UCLA CMV Retinopathy Study Group. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome. Arch Ophthalmol. 1989;107(12):1759–1766. - PubMed
-
- Wei LL, Park SS, Skiest DJ. Prevalence of visual symptoms among patients with newly diagnosed cytomegalovirus retinitis. Retina. 2002;22(3):278–282. - PubMed
-
- Danis RP. The clinical site-reading center partnership in clinical trials. Am J Ophthalmol. 2009;148(6):815–817. - PubMed
-
- Studies of the Ocular Complications of AIDS Research Group. SOCA Cytomegalovirus Retinitis Grading Protocol. Springfield, VA: National Technical Information Service, US Department of Commerce; 1997. NTIS accession PB97-192082.
-
- Weinberg DV, Holbrook JT, Hubbard LD, Davis MD,Jabs DA, Holland GN; Studies of Ocular Complications of AIDS Research Group. Clinician versus reading center assessment of cytomegalovirus retinitis lesion size. Ophthalmology. 2005;112(4):559–566. - PubMed